Informations techniques
Exploitant
Laboratoires PROSTRAKAN PHARMA
Présentation
DROLEPTAN 2,5 mg/ 1ml, solution injectable (IV) B/10 - CIP 561 122-8
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
py7YPfBUMQU7SFYJ